Vitality Watch

Dossier pubmed preclinical 07-jul-2026
Animal model, organoid, or cell-culture result — not yet human

Study on the Effects and Mechanisms of Resveratrol in Improving Cognitive Impairment in Aβ-Induced Alzheimer’s Disease Model Mice.

Key claim: Resveratrol reduces aging markers and improves Aβ-induced Alzheimer-model pathology in mice by activating autophagy and delaying cellular senescence through AMPK/ULK1 and SIRT1/NF-κB pathways.

Abstract

Aging is a major risk factor for neurodegenerative diseases, including Alzheimer’s disease (AD). Targeting cellular senescence has therefore emerged as a promising therapeutic strategy. Resveratrol (RV), a natural polyphenolic compound, exhibits anti-aging properties through the regulation of autophagy and oxidative stress; however, its mechanisms in AD remain incompletely understood. In this study, we investigated the effects and underlying mechanisms of RV in an Aβ1-42-induced AD model. In vivo, RV administration significantly reduced the expression of aging-related markers and activated autophagy-associated signaling pathways. In vitro, RV treatment markedly attenuated Aβ1-42-induced cell viability loss and excessive reactive oxygen species (ROS) production. Further mechanistic analyses demonstrated that RV-induced autophagy activation was closely associated with the AMP-activated protein kinase/UNC-51-like kinase 1 (AMPK/ULK1) and silent information regulator 1/nuclear factor-kappaB (SIRT1/NF-κB) pathways. Collectively, these findings suggest that RV alleviates AD-related pathological processes by promoting autophagy and delaying cellular senescence, highlighting its potential as a therapeutic agent for age-related neurodegenerative diseases.

Why this matters

Resveratrol reduces aging markers and improves Aβ-induced Alzheimer-model pathology in mice by activating autophagy and delaying cellular senescence through AMPK/ULK1 and SIRT1/NF-κB pathways.

Source

Link

Briefing card

Study on the Effects and Mechanisms of Resveratrol in Improving Cognitive Impairment in Aβ-Induced Alzheimer's Disease Model Mice.
Stage: preclinical · pubmed · 07-jul-2026

Resveratrol reduces aging markers and improves Aβ-induced Alzheimer-model pathology in mice by activating autophagy and delaying cellular senescence through AMPK/ULK1 and SIRT1/NF-κB pathways.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.1007/s11481-026-10303-z

build build 880 · 2bcef25 · 2026-11-18